TY  - GEN
AU  - Kim,AeRang
AU  - Dombi,Eva
AU  - Tepas,Kathleen
AU  - Fox,Elizabeth
AU  - Martin,Staci
AU  - Wolters,Pamela
AU  - Balis,Frank M
AU  - Jayaprakash,Nalini
AU  - Turkbey,Baris
AU  - Muradyan,Naira
AU  - Choyke,Peter L
AU  - Reddy,Alyssa
AU  - Korf,Bruce
AU  - Widemann,Brigitte C
TI  - Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas
SN  - 1545-5017
PY  - 2013///0308
KW  - Adolescent
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Child
KW  - Child, Preschool
KW  - Female
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Neurofibroma, Plexiform
KW  - drug therapy
KW  - Neurofibromatosis 1
KW  - complications
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Sorafenib
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/pbc.24281
ER  -